Kral, Ö. Et Al. 2024. Development of Dermal Lidocaine Nanosuspension Formulation by the Wet Milling Method Using Experimental Design: In Vitro/In Vivo Evaluation. ACS Omega , vol.9, no.52 , 50992-51008.

Kral, Ö., İLBASMIŞ TAMER, S., Han, ., & Tirnaksiz, F., (2024). Development of Dermal Lidocaine Nanosuspension Formulation by the Wet Milling Method Using Experimental Design: In Vitro/In Vivo Evaluation. ACS Omega , vol.9, no.52, 50992-51008.

Kral, Özlem Et Al. "Development of Dermal Lidocaine Nanosuspension Formulation by the Wet Milling Method Using Experimental Design: In Vitro/In Vivo Evaluation," ACS Omega , vol.9, no.52, 50992-51008, 2024

Kral, Özlem Et Al. "Development of Dermal Lidocaine Nanosuspension Formulation by the Wet Milling Method Using Experimental Design: In Vitro/In Vivo Evaluation." ACS Omega , vol.9, no.52, pp.50992-51008, 2024

Kral, Ö. Et Al. (2024) . "Development of Dermal Lidocaine Nanosuspension Formulation by the Wet Milling Method Using Experimental Design: In Vitro/In Vivo Evaluation." ACS Omega , vol.9, no.52, pp.50992-51008.

@article{article, author={Özlem Kral Et Al. }, title={Development of Dermal Lidocaine Nanosuspension Formulation by the Wet Milling Method Using Experimental Design: In Vitro/In Vivo Evaluation}, journal={ACS Omega}, year=2024, pages={50992-51008} }